Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma

PURPOSE: Patients with hypopharyngeal carcinoma (HPC) often progress to an advanced clinical stage at diagnosis. Cisplatin has been widely used in first-line chemotherapy for advanced HPC. However, acquired chemotherapeutic resistance leads to recurrence, metastasis, and a poor survival rate. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Shiyu, Tan, Guolin, Wang, Tiansheng, Wang, Xianyao, Zhou, Zheng, Xiao, Jian, Li, Tieqi, Zhang, Gehou, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444389/
https://www.ncbi.nlm.nih.gov/pubmed/36072966
http://dx.doi.org/10.1155/2022/9341731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444389/
https://www.ncbi.nlm.nih.gov/pubmed/36072966
http://dx.doi.org/10.1155/2022/9341731

Ejemplares similares